Copyright
©The Author(s) 2022.
World J Gastroenterol. Jan 28, 2022; 28(4): 464-478
Published online Jan 28, 2022. doi: 10.3748/wjg.v28.i4.464
Published online Jan 28, 2022. doi: 10.3748/wjg.v28.i4.464
Figure 1 Expression and prognostic value of DEAD-box helicase 51 in esophageal cancer.
A: Immunohistochemistry analysis of DEAD-box helicase 51 (DDX51) expression in tumor tissues and paired normal tissues of patients with esophageal squamous cell carcinoma (ESCC); B: Quantitative PCR detection of DDX51 mRNA expression in the tumor tissues (n = 118) and paired normal tissues (n = 118) of patients with ESCC, aP < 0.05; C: Survival curves of ESCC patients with high or low expression (P = 0.0036).
- Citation: Hu DX, Sun QF, Xu L, Lu HD, Zhang F, Li ZM, Zhang MY. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway. World J Gastroenterol 2022; 28(4): 464-478
- URL: https://www.wjgnet.com/1007-9327/full/v28/i4/464.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i4.464